INTRODUCTION
Treatment of melanoma of the head and neck is a complex issue. The behaviour of this malignancy is aggressive, and it has an overall worse prognosis than that of other skin sites 19 .
Histological involvement of regional lymph nodes by metastases of malignant melanoma in the head and neck region is a very poor prognostic sign, and it appears to carry an even more ominous prognosis than histological involvement of axillary or inguinal lymph nodes in draining melanomas of the trunk or extremities 32 . Therefore, accurate localization of pathologically involved cervical lymph nodes is crucial in the treatment of these patients.
Some studies have reported that patterns of lymphatic drainage from a given area of skin in patients with melanoma are highly variable from patient to patient and that accurate clinical prediction of lymphatic pathways is not possible 39, 41 . This study is design to determine the accuracy of clinically predicting the distribution of pathologically involved lymph nodes related to primary melanoma site.
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MATERIALS AND METHODS
The medical records of patients with primary cutaneous head and neck melanomas, who were referred to the Department of Maxillofacial Surgery of the University Hospital Dubrava, University of Zagreb School of Medicine, from January 1, 1985 to December 31, 2005 , were reviewed retrospectively. Patients with primary melanomas of the head and neck who underwent primary surgical treatment were included. The exclusion criteria were as follows:
patients who did not undergo primary surgical treatment; patients with primary cutaneous melanoma localized outside of the head and neck region; patients who had been previously excised, had local recurrence, or neck metastasis and patients with external ear melanomas.
Among 145 patients with cutaneous head and neck melanomas, 39 patients underwent wide local excision due to their thickness (<1mm), while 106 patients underwent neck dissection.
All cases were re-classified according to the AJCC melanoma staging system 1 . Primary tumor mitotic rate has been excluded from our survival analysis as potential predictive factor because it was not a factor earlier classifications and data on this are incomplete and unreliable. The harvested lymph nodes were evaluated using serial sectioning with hematoxylin-eosin (H&E) staining while immunohistochemical staining with antibodies for S-100p, HMB-45 and MART-1 were used for patients when H&E did not reveal evidence of metastatic disease since this procedure has 10-30% higher sensitivity for identifying micrometastases compared with conventional H&E staining 9, 17, 24, 42 . The location of pathologically positive lymph nodes was compared with clinically predicted spread, and all patients with metastatic disease in areas outside of predicted drainage patterns (including drainage to contralateral lymph node of neck) were considered aberrant. Follow-up intervals were calculated in months from the date of first treatment at our Department to the date of last follow-up or death. When all node-positive (n=45) and node-negative (n=51) patients were considered as two different groups, the cumulative survival was 44% and 87% at 5 years, respectively (P< 0.01). suffered myocardial infarction and died 6 days after surgical therapy. As adjuvant treatment, the majority of patients received interferon (n=23), followed by chemotherapy (n=18), chemotherapy with radiation (n=3), radiation alone (n=1), and radiation with immunotherapy (n=1) and they were all included in the study group.
Statistical methods
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After eliminating patients with histological negative necks (n= 51), patients with nodal metastases from an unknown primary melanoma site (n= 6) and patients with primaries outside the head and neck region with regional metastases (n= 4), 45 patients were eligible for this study. Clinical characteristics of these patients are summarized in Table 2 . The study group included 28 men and 17 women with a median age of 49 years (range, 21-75 years).
The mean tumour thickness in the study group was 4.2 mm (range, 1-10 mm). Based on thickness, melanomas were stratified into thin (n=0), intermediate (n=17) and thick (n=28).
The number of nodal metastases per patient averaged 3.98 (range, 1-17).
The skin of the head and neck was divided into 6 anatomic subsites ( Figure 5 ). Pathological findings were correlated with primary melanoma site, which was assigned to the one of six anatomic subsites and then compared with clinical prediction. The algorithm for determining drainage was based according to the patterns described by O' Brien et al. 30 . The correlation between clinical prediction based on primary melanoma site and anatomic distribution of nodal metastases is shown in Table 3 .
Primary melanomas of the forehead and face were metastasing to the parotid gland or neck . Finally, despite the fact that sentinel lymph node biopsy (SLNB) has been adopted into clinical practice as reliable staging modality, there are lots of arguments against it, such as increased incidence of nodal (regional and in-transit) recurrence in sentinel lymph nodes (SLN) negative patients, possibility of false-negative results, difficult identification of SLN if they are located close to primary site, SLN found in multiple node fields in contrast to melanomas located on extremities which usually drain to only 1 field, SLN in parotid region which are often very small, may be difficult to find, and their removal may put the facial nerve at risk 8, 10, 12, 15, 16, 29, 36, 37 . However, some authors reported that intraparotid SLN biopsy is a reliable, accurate, and safe procedure for staging cutaneous head and neck melanoma 23 . The finding that 1 in 4 patients had aberrant metastatic spread, which was not predicted clinically, is perhaps an indication that some patients may benefit from SLNB and lymphoscintigraphy. In this retrospective study, positron emission tomography (PET) was not used. Although PET's inability to identify microscopic disease suggest that is of limited use in evaluating patients with stage I-II disease, PET can be helpful in managing patients with stage III melanoma in whom further surgery is contemplated 38 . Furthermore, Iagaru et al. 18 showed that PET has a sensitivity of 89% and a specificity of 88% for melanoma detection during restaging, and therefore should be an integral part in evaluation of patients with high-risk melanoma, prior to selection of the optimal treatment modality.
On the basis of controlled trials and our clinical experience we believe that ELND should not be forgotten treatment modality and that some subgroups of patients may benefit from this procedure.
It is generally agreed that preoperative clinical prediction of potential nodal metastatic sites based on anatomic location of the primary melanoma is difficult because of highly variable lymphatic pathways in the head and neck 39, 41 . In the present study, we have aimed to evaluate patterns of metastatic spread from primary melanoma site and to determine appropriate extent of surgery based on histological evaluation of neck dissection specimens.
This study included patients with positive lymph node pathology detected in the neck, the parotid gland, combined parotid and neck involvement, and metastatic disease outside the parotid region and five main neck levels of lymph nodes. Tumour thickness was the most important factor in determining whether or not to perform an elective neck dissection (END).
All patients with histological confirmed cutaneous melanoma thicker than 1mm or thicker than 0.7mm with a Clark level of 4 were considered candidates for END. No strict criteria were used to select the extent of parotid gland surgery; however patients with thick melanomas (>4mm) were more likely to undergo total parotidectomy, no matter if the procedure was performed on an elective or therapeutic basis. The procedure was done in On the other side, patients with posterior scalp and posterior neck primaries had no involvement of the submandibular and submental triangles, or the parotid gland, so it may be justified to perform just a regional lymphadenectomy, excluding dissection of level 1 and any 14 parotidectomy. Also, patients with upper neck melanomas had no metastatic disease at levels 4 and 5 and therefore it is recommended to exclude lower jugular lymph nodes and posterior triangle when considering surgical options and to rather perform a supraomohyoid dissection.
Shah et al. 33 identified similar patterns of metastatic spread from primary melanoma sites.
According to results of this study, 5 of 45 patients had drainage in sites outside the parotid gland and five main levels of the neck. These patients demonstrated postauricular, nuchal and paratracheal lymph node involvement. Metastatic disease in postauricular and nuchal lymphatics was associated with posterior scalp and neck primaries. These lymph nodes are not typically dissected in standard neck dissections and spreading to these lymph node groups may be suspected. Previous studies also reported lymphatic drainage to these "discordant"
sites from posterior primaries stressing that posterior neck dissection is mandatory and effective procedure to adequately resect the primary lymphatics which provides control of regional metastatic disease 11, 14 . On the other hand, O'Brien et al. 30 reported metastatic spread to postauricular lymph nodes (1 of 18 patients with posterior scalp primaries and 2 of 26 patients with coronal scalp melanomas) but no nuchal or occipital lymph node involvement was seen. Larson et al. 20 stressed that among the sites of origin in the head and neck, melanoma of the scalp and neck carries the highest mortality, with 10-year survival being only 60%. Our recommended operations based on anatomic distribution of regional metastases are summarized in Figure 6 .
Also, results of this study show no statistically significant difference in pathologically involved levels between elective lymphadenectomies and therapeutic procedures and a similar distribution of nodal metastases no matter whether neck dissection has been performed based on an elective or therapeutic basis. 33 .
According to results of this study, patients with recurrence were predominant males (18 vs.
11), had greater average melanoma thickness, higher percentage of 3 or more pathologically involved lymph nodes, higher incidence of extracapsular extension and higher percentage of parotid region drainage. However, none of the covariates tested (for recurrence rates) here were found to be statistically significant. Also, all this variables were compared using survival curves and only male gender differed significantly with respect to survival. On the other hand, some authors identified male gender, primary tumour thickness, type of neck dissection (elective vs. therapeutic), ECE, and number and size of regional metastases, as statistically significant independent negative prognostic factors 21, 26 .
In conclusion, cutaneous melanomas of the head and neck metastasized to clinically predict Abbreviations: 
